Gilead Sciences is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases. In 2017 Gilead acquired Kite.At Kite, the singular focus is cell therapy to treat and potentially cure cancer. The goal is to bring the promise of cell therapy to as many eligible patients as possible who may benefit.